Significance of Glypican-3 (GPC3) Expression in Hepatocellular Cancer Diagnosis

被引:50
|
作者
Sun, Bin [1 ]
Huang, Zhi [2 ]
Wang, Bi [3 ]
Yu, Yanglong [4 ]
Lin, Shihai [1 ]
Luo, Lei [1 ]
Wang, Yuzhu [1 ]
Huang, Zheng [1 ]
机构
[1] First Peoples Hosp Guiyang, Dept Intervent Radiol, Guiyang, Guizhou, Peoples R China
[2] Guizhou Med Univ, Affiliated Baiyun Hosp, Dept Intervent Radiol, Guiyang, Guizhou, Peoples R China
[3] Maternal & Child Hlth Hosp Guiyang City, Dept Prepotency, Guiyang, Guizhou, Peoples R China
[4] Guizhou Med Univ, Dept Clin Med, Guiyang, Guizhou, Peoples R China
来源
MEDICAL SCIENCE MONITOR | 2017年 / 23卷
关键词
Antifreeze Proteins; Type II; Type III; Genes; rev; Headache Disorders; Primary; MART-1; Antigen; CELL-PROLIFERATION; CARCINOMA TISSUES; HEPATITIS; THERAPY; MARKER;
D O I
10.12659/MSM.899198
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Primary hepatocellular carcinoma (HCC) is a malignant tumor that is common China. Early diagnosis is of great significance for improving treatment efficiency. GPC3 level is closely related to HCC occurrence. This study investigated GPC3 expression in HCC patient serum and tissue, and assessed the significance of GPC3 combined AFP detection in HCC diagnosis. Material/Methods: A total of 76 HCC patients in our hospital were enrolled. Immunohistochemistry was applied to test GPC3 expression in cancer tissue and para-carcinoma tissue. ELISA and RT-PCR were used to detect GPC3 and AFP level in serum. The significance of GPC3 single or combined AFP detection in HCC diagnosis was analyzed. Results: Immunohistochemistry showed that the GPC3 positive expression rate was obviously elevated in HCC tissue (P<0.01). Combination detection of AFP and GPC3 presented significantly higher sensitivity and specificity in HCC than single AFP or GPC3 detection. ELISA showed no significant difference in sensitivity, specificity, or accuracy compared with RT-PCR. Conclusions: Serum GPC3 was overexpressed in HCC patients. Combination detection of serum AFP and GPC3 can enhance accuracy and efficacy of HCC diagnosis.
引用
收藏
页码:850 / 855
页数:6
相关论文
共 50 条
  • [21] The Expression of Glypican-3 in Colorectal Cancer
    Sonia Azizpour
    Razieh Ezati
    Massoud Saidijam
    Amirnader Emami Razavi
    Farid Azizi Jalilian
    Ali Mahdavinezhad
    Hamid Eslami
    Alireza Soltanian
    Hadiseh Mohammadpour
    Fatemeh Kamali
    Razieh Amini
    Cytology and Genetics, 2019, 53 : 430 - 440
  • [22] Zoledronate induce expansion of glypican-3 (GPC3) peptide specific cytotoxic T ILymphocytes sufficient for adoptive cancer immunotherapy
    Yoshikawa, Toshiaki
    Takahara, Masashi
    Tomiyama, Mai
    Kuroda, Ayumi
    Shirakawa, Hirofumi
    Nobuoka, Daisuke
    Sawada, Yu
    Sakemura, Noriko
    Nieda, Mie
    Maekawa, Ryuji
    Nakatsura, Tetsuya
    CANCER RESEARCH, 2012, 72
  • [23] Evaluation for clinical utility of GPC3, measured by a commercially available ELISA kit with Glypican-3 (GPC3) antibody, as a serological and histological marker for hepatocellular carcinoma (vol 40, pg 477, 2010)
    Yasuda, E.
    Kumada, T.
    Toyoda, H.
    Kaneoka, Y.
    Maeda, A.
    Okuda, S.
    Yoshimi, N.
    Kozawa, O.
    HEPATOLOGY RESEARCH, 2011, 41 (01) : 101 - 101
  • [24] Prognostic significance of glypican-3 expression in hepatocellular carcinoma A meta-analysis
    Liu, Hong
    Yang, Chunmei
    Lu, Wenzhu
    Zeng, Yong
    MEDICINE, 2018, 97 (04)
  • [25] Proof of glypican-3 (GPC3) peptide specific CTLs infiltrating into tumor tissue derived from advanced HCC patient vaccinated with GPC3 peptide.
    Yoshikawa, Toshiaki
    Sakai, Mayuko
    Ofuji, Kazuya
    Takahashi, Mari
    Shimomura, Manami
    Sawada, Yu
    Nobuoka, Daisuke
    Nakatsura, Tetsuya
    CANCER RESEARCH, 2013, 73
  • [26] Imaging the expression of glypican-3 in hepatocellular carcinoma by PET
    Wang, Zhen
    Han, Yan-Jiang
    Huang, Shun
    Wang, Meng
    Zhou, Wen-Lan
    Li, Hong-Sheng
    Wang, Quan-Shi
    Wu, Hu-Bing
    AMINO ACIDS, 2018, 50 (02) : 309 - 320
  • [27] Long noncoding RNA glypican 3 (GPC3) antisense transcript 1 promotes hepatocellular carcinoma progression via epigenetically activating GPC3
    Zhu, Xiao-ting
    Yuan, Ji-hang
    Zhu, Teng-teng
    Li, Yang-yang
    Cheng, Xiao-yang
    FEBS JOURNAL, 2016, 283 (20) : 3739 - 3754
  • [28] Imaging the expression of glypican-3 in hepatocellular carcinoma by PET
    Zhen Wang
    Yan-Jiang Han
    Shun Huang
    Meng Wang
    Wen-Lan Zhou
    Hong-Sheng Li
    Quan-Shi Wang
    Hu-Bing Wu
    Amino Acids, 2018, 50 : 309 - 320
  • [29] Identification of Glypican-3 (GPC3) Expression in a Lethal Subgroup of Refractory Cisplatin-Resistant Testicular Germ-Cell Tumors
    Chahoud, Jad
    Zhang, Miao
    Pisters, Louis L.
    Lin, Song-Chang
    Lin, Sue-Hwa
    Tu, Shi-Ming
    CLINICAL GENITOURINARY CANCER, 2018, 16 (05) : 325 - 327
  • [30] Somatic glypican 3 (GPC3) mutations in Wilms' tumour
    White, GRM
    Kelsey, AM
    Varley, JM
    Birch, JM
    BRITISH JOURNAL OF CANCER, 2002, 86 (12) : 1920 - 1922